CD274 and neoplasm: Specifically, approximately 44.44% of the tumor samples with high TLR9 expression showed strong PD-L1 staining, and 75.47% of those with low TLR9 expression showed weak PD-L1 staining or no PD-L1 staining (p < 0.001) (Figure 5D).